You are here

Article Text

Article menu
Download PDFPDF
Commentary
Inhibition of monoacylglycerol lipase for the treatment of liver disease: tempting but still playing with fire

https://doi.org/10.1136/gutjnl-2018-317520

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors CH wrote the commentary.

    • Funding This work was supported by the German Research Foundation (DFG; HE 2458/15-2 and HE 2458/18-2) and the Interdisciplinary Center for Clinical Research of the University Hospital Erlangen (IZKF; 17-04-10-1).

    • Competing interests None declared.

    • Patient consent Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles

    • Hepatology
      Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
      Aida Habib Dina Chokr JingHong Wan Pushpa Hegde Morgane Mabire Matthieu Siebert Lara Ribeiro-Parenti Maude Le Gall Philippe Lettéron Nathalie Pilard Abdellah Mansouri Arthur Brouillet Matteo Tardelli Emmanuel Weiss Pauline Le Faouder Hervé Guillou Benjamin F Cravatt Richard Moreau Michael Trauner Sophie Lotersztajn
      Gut 2018; 68 522-532 Published Online First: 09 Oct 2018. doi: 10.1136/gutjnl-2018-316137